Nadieh Samiaei, NP
Nurse Practitioner · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 13 years
- Graduated 2013
Offices
1 location · Bay Area Community Health · 106 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Nadieh Samiaei’s office at (510) 770-8040 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G23284 · Cancelled
Licence status: Cancelled · since 1972 · University of California San Francisco School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$10,543 in 2024
Medicaid paid $10,543 for 3,013 billed services this clinician did in 2024, up to 135 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 1,220 | $5,836 |
| Short return visit | 1,252 | $3,546 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 75 | $351 |
| Hepatitis B vaccine (HepB), CpG-adjuvanted, adult dosage, 2 dose or 4 dose schedule, for intramuscular use | 14 | $240 |
| Return visit (30+ min) | 35 | $150 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 17 | $110 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 113 | $80 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 31 | $62 |
| Hemoglobin; by copper sulfate method, non-automated | 171 | $59 |
| Screening performed and negative | 39 | $58 |
| Gonadotropin, chorionic (hCG); qualitative | 46 | $52 |
| 2024 | 3,013 | 11 | 135 | $10,543 |
| 2023 | 2,174 | 12 | 168 | $98,598 |
| 2022 | 6,097 | 10 | 227 | $394,888 |
| 2021 | 1,048 | 5 | 140 | $75,756 |
| 2019 | 143 | 4 | 23 | $2,674 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 557 | $90,623 |
| Short return visit (20+ min) | 1,041 | $5,189 |
| Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use | 14 | $872 |
| Short return visit | 197 | $785 |
| New patient visit (30+ min) | 96 | $589 |
| Return visit (30+ min) | 87 | $362 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 76 | $140 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 12 | $21 |
| Hemoglobin; by copper sulfate method, non-automated | 33 | $18 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 28 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 18 | $0 |
| Screening performed and negative | 15 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 2,020 | $352,536 |
| Short return visit (20+ min) | 3,352 | $36,025 |
| Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use | 46 | $2,675 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 61 | $1,176 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 18-39 years | 72 | $890 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 193 | $649 |
| Short return visit | 75 | $527 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 248 | $380 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 18 | $29 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 40-64 years | 12 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 400 | $69,482 |
| Short return visit (20+ min) | 574 | $5,511 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 17 | $327 |
| Return visit (30+ min) | 24 | $319 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 33 | $117 |
2019
| Clinic visit/encounter, all-inclusive | 18 | $2,436 |
| Short return visit (20+ min) | 99 | $238 |
| HEMOGLOBIN | 13 | $0 |
| Pure tone audiometry (threshold); air only | 13 | $0 |
Drugs they prescribed that Part D paid
$34,057
Pharmacies billed $34,057 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 639) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
580 generic and fewer than 11 brand-name prescriptions · $34,057 in drug cost · 21 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 23 | $895 | $39 |
| Atorvastatin | 66 | $304 | $5 |
| Levothyroxine | 34 | $300 | $9 |
| Metoprolol | 20 | $254 | $13 |
| Amlodipine Besylate | 45 | $200 | $4 |
See all 14 drugs
| Albuterol Sulfate Hfa | 23 | $895 | $39 |
| Atorvastatin | 66 | $304 | $5 |
| Levothyroxine | 34 | $300 | $9 |
| Metoprolol | 20 | $254 | $13 |
| Amlodipine Besylate | 45 | $200 | $4 |
| Losartan | 26 | $140 | $5 |
| Metformin | 26 | $134 | $5 |
| Pravastatin | 13 | $132 | $10 |
| Omeprazole | 21 | $120 | $6 |
| Lisinopril | 22 | $115 | $5 |
| Fluticasone Propionate | 12 | $91 | $8 |
| Hydrochlorothiazide | 27 | $58 | $2 |
| Ibuprofen | 19 | $40 | $2 |
| Simvastatin | 12 | $38 | $3 |
Year by year
| 2024 | 639 | 144 | 0% (0) | None | $34,057 |
| 2023 | 480 | 137 | 0% (0) | None | $28,690 |
| 2022 | 770 | 93 | 0% (0) | 10% | $43,617 |
| 2021 | 36 | 15 | 0% (0) | None | $1,138 |
| 2020 | 21 | None | 0% (0) | None | $230 |
| 2019 | 164 | 32 | 0% (0) | None | $3,650 |
| 2018 | 18 | 12 | 0% (0) | None | $250 |
| 2017 | 11 | None | 0% (0) | 0% | $99 |
| 2016 | 665 | 69 | None | 10% | $15,496 |
| 2015 | 1,126 | 88 | None | 12% | $29,148 |
| 2014 | 331 | 60 | None | None | $9,869 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Albuterol Sulfate Hfa | 23 | $813 | $35 |
| Atorvastatin | 34 | $793 | $23 |
| Losartan | 16 | $569 | $36 |
| Amlodipine Besylate | 35 | $430 | $12 |
| Metformin | 25 | $425 | $17 |
| Lisinopril | 23 | $319 | $14 |
| Simvastatin | 17 | $277 | $16 |
| Gabapentin | 24 | $241 | $10 |
| Omeprazole | 13 | $203 | $16 |
| Furosemide | 11 | $82 | $7 |
| Hydrochlorothiazide | 13 | $63 | $5 |
2022: 17 drugs
| Atorvastatin | 88 | $1,194 | $14 |
| Amlodipine Besylate | 81 | $730 | $9 |
| Losartan | 42 | $726 | $17 |
| Albuterol Sulfate Hfa | 15 | $579 | $39 |
| Metformin | 53 | $510 | $10 |
| Levothyroxine | 33 | $485 | $15 |
| Gabapentin | 17 | $479 | $28 |
| Losartan-Hydrochlorothiazide | 13 | $222 | $17 |
| Lisinopril | 47 | $216 | $5 |
| Allopurinol | 12 | $176 | $15 |
| Omeprazole | 15 | $150 | $10 |
| Famotidine | 16 | $141 | $9 |
| Ibuprofen | 27 | $116 | $4 |
| Glipizide | 12 | $103 | $9 |
| Simvastatin | 13 | $70 | $5 |
| Hydrochlorothiazide | 18 | $51 | $3 |
| Citalopram Hbr | 12 | $34 | $3 |
2019: 4 drugs
| Amlodipine Besylate | 31 | $245 | $8 |
| Simvastatin | 18 | $188 | $10 |
| Metformin | 12 | $104 | $9 |
| Lisinopril | 11 | $102 | $9 |
2016: 12 drugs
| Lantus Solostar | 13 | $5,457 | $420 |
| Levothyroxine | 38 | $514 | $14 |
| Atorvastatin | 51 | $511 | $10 |
| Pravastatin | 43 | $467 | $11 |
| Lisinopril | 98 | $348 | $4 |
| Metformin | 74 | $347 | $5 |
| Hydrochlorothiazide | 62 | $214 | $3 |
| Simvastatin | 36 | $133 | $4 |
| Amlodipine Besylate | 35 | $98 | $3 |
| Omeprazole | 17 | $91 | $5 |
| Metoprolol | 15 | $90 | $6 |
| Losartan | 18 | $66 | $4 |
2015: 22 drugs
| Lantus Solostar | 15 | $5,884 | $392 |
| Pravastatin | 73 | $1,165 | $16 |
| Proair Hfa | 22 | $1,128 | $51 |
| Atorvastatin | 84 | $678 | $8 |
| Levothyroxine | 47 | $653 | $14 |
| Metformin | 122 | $567 | $5 |
| Lisinopril | 98 | $384 | $4 |
| Glyburide | 22 | $331 | $15 |
| Bd Ultra-Fine Pen Needle | 11 | $313 | $28 |
| Simvastatin | 56 | $243 | $4 |
| Montelukast | 20 | $204 | $10 |
| Amlodipine Besylate | 64 | $199 | $3 |
| Omeprazole | 31 | $188 | $6 |
| Pioglitazone | 15 | $181 | $12 |
| Hydrochlorothiazide | 49 | $148 | $3 |
| Alendronate | 28 | $142 | $5 |
| Naproxen | 19 | $109 | $6 |
| Losartan | 27 | $103 | $4 |
| Terazosin | 15 | $74 | $5 |
| Triamcinolone Acetonide | 11 | $60 | $5 |
| Atenolol | 17 | $36 | $2 |
| Lisinopril-Hydrochlorothiazide | 18 | $35 | $2 |
2014: 10 drugs
| Pravastatin | 11 | $222 | $20 |
| Atorvastatin | 22 | $220 | $10 |
| Metformin | 33 | $175 | $5 |
| Omeprazole | 12 | $109 | $9 |
| Simvastatin | 16 | $97 | $6 |
| Lisinopril | 24 | $86 | $4 |
| Losartan | 12 | $83 | $7 |
| Ibuprofen | 12 | $61 | $5 |
| Naproxen | 11 | $58 | $5 |
| Hydrochlorothiazide | 17 | $46 | $3 |
Money from drug and device companies
$388 in 2025
| 2025 | 8 | 11 | None | $388 |
| 2024 | 5 | 5 | None | $111 |
| 2023 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genzyme | None | $150 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $61 | 3 payments
|
| Gilead Sciences | Biktarvy | $53 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $34 | 1 payment
|
| GlaxoSmithKline | Shingrix | $25 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $22 | 1 payment
|
See all 11 published payments
| Exact Sciences | Meals · 2025-09-25 | Cologuard Collection Kit | $19 |
| Gilead Sciences | Meals · 2025-08-21 | Yeztugo | $23 |
| Hologic Sales and Service | Meals · 2025-07-01 | Aptima | $21 |
| Dynavax Technologies | Meals · 2025-06-24 | Heplisav-B | $22 |
| Exact Sciences | Meals · 2025-06-23 | Cologuard Collection Kit | $26 |
| Dexcom | Meals · 2025-06-12 | Dexcom G6 Transmitter | $34 |
| GlaxoSmithKline | Meals · 2025-05-16 | Shingrix | $25 |
| Genzyme | Meals · 2025-03-18 | None | $150 |
| Abbott Laboratories | Meals · 2025-03-11 | Freestyle Libre 3 | $22 |
| Gilead Sciences | Meals · 2025-03-04 | Biktarvy | $30 |
| Exact Sciences | Meals · 2025-02-27 | Cologuard Collection Kit | $16 |
See earlier years (2024, 2023)
2024: $111
| Gilead Sciences | Biktarvy | $33 | 1 payment
|
| Merck Sharp & Dohme | Gardasil | $25 | 1 payment
|
| Phadia US | Immunocap | $20 | 1 payment
|
| Organon | Nexplanon | $19 | 1 payment
|
| GlaxoSmithKline | Arexvy | $13 | 1 payment
|
2023: $23
| Dynavax Technologies | Heplisav-B | $23 | 1 payment
|
Professional record
- NPI
- 1821409533
- Licence
- CA 23284California G23284: Cancelled
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 13531 Myren Dr, Saratoga, CA, 95070
- NPI first listed
- 2014-05-15
- NPI last updated
- 2014-05-15
This is when the NPI record was last certified, not a medical board exam.